Flow Traders Us Cut Its Credit Suisse Ag/Nassau (XIV) Stake by $15.26 Million as Share Value Rose; Healthequity (HQY) Holder Berkley W R Has Decreased Its Stake

October 7, 2017 - By Adrian Erickson

Berkley W R Corp decreased its stake in Healthequity Inc (HQY) by 10.04% based on its latest 2017Q2 regulatory filing with the SEC. Berkley W R Corp sold 879,987 shares as the company’s stock rose 4.44% with the market. The institutional investor held 7.88M shares of the miscellaneous company at the end of 2017Q2, valued at $392.82 million, down from 8.76M at the end of the previous reported quarter. Berkley W R Corp who had been investing in Healthequity Inc for a number of months, seems to be less bullish one the $3.14B market cap company. The stock increased 0.08% or $0.04 on October 6, reaching $51.91. About 335,944 shares traded. Healthequity Inc (NASDAQ:HQY) has risen 95.58% since October 7, 2016 and is uptrending. It has outperformed by 78.88% the S&P500.

Flow Traders Us Llc decreased its stake in Credit Suisse Ag/Nassau (XIV) by 34.4% based on its latest 2017Q2 regulatory filing with the SEC. Flow Traders Us Llc sold 183,828 shares as the company’s stock rose 10.72% with the market. The institutional investor held 350,585 shares of the investment bankers and brokers and service company at the end of 2017Q2, valued at $29.26 million, down from 534,413 at the end of the previous reported quarter. Flow Traders Us Llc who had been investing in Credit Suisse Ag/Nassau for a number of months, seems to be less bullish one the $1.11 billion market cap company. The stock increased 0.03% or $0.03 on October 6, reaching $102.76. About 6.79M shares traded. Credit Suisse AG – VelocityShares Daily Inverse VIX Short Term ETN (NASDAQ:XIV) has risen 166.34% since October 7, 2016 and is uptrending. It has outperformed by 149.64% the S&P500.

More news for Healthequity Inc (NASDAQ:HQY) were recently published by: Globenewswire.com, which released: “HealthEquity to Present at Conferences in September” on September 12, 2017. Globenewswire.com‘s article titled: “HealthEquity to Serve Alliant Credit Union HSA Members” and published on September 18, 2017 is yet another important article.

Berkley W R Corp, which manages about $814.86M US Long portfolio, upped its stake in Kate Spade & Co (NYSE:KATE) by 134,828 shares to 159,028 shares, valued at $2.94M in 2017Q2, according to the filing. It also increased its holding in Fintech Acquisition Corp Ii by 291,270 shares in the quarter, for a total of 581,340 shares, and has risen its stake in Electrum Spl Acquisition Cor.

Among 12 analysts covering HealthEquity Inc (NASDAQ:HQY), 10 have Buy rating, 0 Sell and 2 Hold. Therefore 83% are positive. HealthEquity Inc had 24 analyst reports since August 18, 2015 according to SRatingsIntel. Chardan Capital Markets maintained it with “Buy” rating and $53 target in Wednesday, March 22 report. Cantor Fitzgerald maintained the stock with “Buy” rating in Wednesday, June 7 report. KeyBanc Capital Markets initiated the stock with “Overweight” rating in Tuesday, January 24 report. Robert W. Baird maintained Healthequity Inc (NASDAQ:HQY) rating on Wednesday, September 7. Robert W. Baird has “Neutral” rating and $35 target. The company was maintained on Tuesday, September 5 by Cantor Fitzgerald. The firm has “Outperform” rating given on Tuesday, December 8 by Barrington Research. The rating was maintained by SunTrust on Wednesday, June 8 with “Buy”. The rating was maintained by Cantor Fitzgerald on Thursday, July 13 with “Buy”. The firm earned “Market Outperform” rating on Wednesday, March 23 by Avondale. The stock has “Buy” rating by Suntrust Robinson on Wednesday, June 8.

Analysts await Healthequity Inc (NASDAQ:HQY) to report earnings on December, 5. They expect $0.13 EPS, up 30.00% or $0.03 from last year’s $0.1 per share. HQY’s profit will be $7.86 million for 99.83 P/E if the $0.13 EPS becomes a reality. After $0.27 actual EPS reported by Healthequity Inc for the previous quarter, Wall Street now forecasts -51.85% negative EPS growth.

More notable recent Credit Suisse AG – VelocityShares Daily Inverse VIX Short Term ETN (NASDAQ:XIV) news were published by: Benzinga.com which released: “What Is The VIX, And What Does It Do?” on August 10, 2017, also Seekingalpha.com with their article: “Where Do XIV And SVXY Go From Here?” published on February 24, 2016, Seekingalpha.com published: “How Does VelocityShares Daily Inverse VIX Short-Term ETN Work?” on May 14, 2014. More interesting news about Credit Suisse AG – VelocityShares Daily Inverse VIX Short Term ETN (NASDAQ:XIV) were released by: Seekingalpha.com and their article: “The #1 Stock In The World” published on June 08, 2015 as well as Seekingalpha.com‘s news article titled: “XIV: What You Need To Know Before Buying” with publication date: October 31, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

Twitter Auto Publish Powered By : XYZScripts.com